SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fermenta Biotech informs about outcome of board meeting

11 Nov 2022 Evaluate
Fermenta Biotech has informed that the Board of Directors of the Company at its meeting held on November 11, 2022 has approved the unaudited financial results for the quarter and half year ended September 30, 2022 (Standalone and Consolidated) as enclosed. It has enclosed the Limited Review Report dated November 11, 2022 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, SRBC & Co. LLP. The Board meeting commenced at 11.45 am and concluded at 02.55 pm.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

312.55 -9.30 (-2.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×